Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Reith

Showing results (131-140 of 233) with videos related to

Pageof 24
Sort By:
Bioorganic & Medicinal Chemistry Letters|December 21, 2017
Latch and trigger role for R445 in DAT transport explains molecular basis of DTDSMaarten E A Reith, Kymry T Jones, Juan Zhen, et al.
Bioorganic & Medicinal Chemistry|November 3, 2004
Structural requirements for 2,4- and 3,6-disubstituted pyran biomimetics of cis-(6-benzhydryl-piperidin-3-yl)-benzylamine compounds to interact with monoamine transportersShijun Zhang, Juan Zhen, Maarten E A Reith, et al.
Journal of Medicinal Chemistry|February 12, 2010
Discovery of 4-(4-(2-((5-Hydroxy-1,2,3,4-tetrahydronaphthalen-2-yl)(propyl)amino)ethyl)piperazin-1-yl)quinolin-8-ol and its analogues as highly potent dopamine D2/D3 agonists and as iron chelator: in vivo activity indicates potential application in symptomatic and neuroprotective therapy for Parkinson's diseaseBalaram Ghosh, Tamara Antonio, Maarten E A Reith, et al.
Journal of Neurochemistry|May 25, 2010
Interrelation of dopamine transporter oligomerization and surface presence as studied with mutant transporter proteins and amphetamineYan Li, Shu-Yuan Cheng, Nianhang Chen, et al.
European Journal of Pharmacology|October 25, 2003
Inhibition by arachidonic acid and other fatty acids of dopamine uptake at the human dopamine transporterNianhang Chen, Michael Appell, Janet L Berfield, et al.
Journal of Medicinal Chemistry|May 31, 2012
Structure-activity relationship study of N⁶-(2-(4-(1H-Indol-5-yl)piperazin-1-yl)ethyl)-N⁶-propyl-4,5,6,7-tetrahydrobenzo[d]thiazole-2,6-diamine analogues: development of highly selective D3 dopamine receptor agonists along with a highly potent D2/D3 agonist and their pharmacological characterizationMark Johnson, Tamara Antonio, Maarten E A Reith, et al.
The Journal of Biological Chemistry|December 9, 2003
Aspartate 345 of the dopamine transporter is critical for conformational changes in substrate translocation and cocaine bindingNianhang Chen, Judy Rickey, Janet L Berfield, et al.
Oral Oncology|September 21, 2001
Abnormal DNA content predicts the occurrence of carcinomas in non-dysplastic oral white patchesJ Sudbø, T Ried, M Bryne, et al.
Cell and Tissue Research|January 1, 1986
An epidermal proliferative unit-like structure in the epithelium of mouse bladder observed by backscattered electron imagingF Thiébaut, J B Reitan, K Feren, et al.
Annals of Emergency Medicine|February 1, 2017
Preformatted admission charts for poisoning admissions facilitate clinical assessment and researchNicholas A Buckler, Ian M Whyte, Andrew H Dawson, et al.
Pageof 24

Showing results (131-140 of 233) with videos related to

Sort By:
Pageof 24
Bioorganic & Medicinal Chemistry Letters|December 21, 2017
Latch and trigger role for R445 in DAT transport explains molecular basis of DTDSMaarten E A Reith, Kymry T Jones, Juan Zhen, et al.
Bioorganic & Medicinal Chemistry|November 3, 2004
Structural requirements for 2,4- and 3,6-disubstituted pyran biomimetics of cis-(6-benzhydryl-piperidin-3-yl)-benzylamine compounds to interact with monoamine transportersShijun Zhang, Juan Zhen, Maarten E A Reith, et al.
Journal of Medicinal Chemistry|February 12, 2010
Discovery of 4-(4-(2-((5-Hydroxy-1,2,3,4-tetrahydronaphthalen-2-yl)(propyl)amino)ethyl)piperazin-1-yl)quinolin-8-ol and its analogues as highly potent dopamine D2/D3 agonists and as iron chelator: in vivo activity indicates potential application in symptomatic and neuroprotective therapy for Parkinson's diseaseBalaram Ghosh, Tamara Antonio, Maarten E A Reith, et al.
Journal of Neurochemistry|May 25, 2010
Interrelation of dopamine transporter oligomerization and surface presence as studied with mutant transporter proteins and amphetamineYan Li, Shu-Yuan Cheng, Nianhang Chen, et al.
European Journal of Pharmacology|October 25, 2003
Inhibition by arachidonic acid and other fatty acids of dopamine uptake at the human dopamine transporterNianhang Chen, Michael Appell, Janet L Berfield, et al.
Journal of Medicinal Chemistry|May 31, 2012
Structure-activity relationship study of N⁶-(2-(4-(1H-Indol-5-yl)piperazin-1-yl)ethyl)-N⁶-propyl-4,5,6,7-tetrahydrobenzo[d]thiazole-2,6-diamine analogues: development of highly selective D3 dopamine receptor agonists along with a highly potent D2/D3 agonist and their pharmacological characterizationMark Johnson, Tamara Antonio, Maarten E A Reith, et al.
The Journal of Biological Chemistry|December 9, 2003
Aspartate 345 of the dopamine transporter is critical for conformational changes in substrate translocation and cocaine bindingNianhang Chen, Judy Rickey, Janet L Berfield, et al.
Oral Oncology|September 21, 2001
Abnormal DNA content predicts the occurrence of carcinomas in non-dysplastic oral white patchesJ Sudbø, T Ried, M Bryne, et al.
Cell and Tissue Research|January 1, 1986
An epidermal proliferative unit-like structure in the epithelium of mouse bladder observed by backscattered electron imagingF Thiébaut, J B Reitan, K Feren, et al.
Annals of Emergency Medicine|February 1, 2017
Preformatted admission charts for poisoning admissions facilitate clinical assessment and researchNicholas A Buckler, Ian M Whyte, Andrew H Dawson, et al.
Pageof 24